🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #391

Cancer - Press review (July 16, 2011) – Revue de presse (16 juillet 2011)

#391
From: SciMedWeb
Date: Sat, 16 Jul 2011 08:38
213 lines
10583 bytes
Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review  (July 16, 2011) – Revue de presse (16 juillet 2011)



Study: More U.S. men die from cancer than women
Men in the United States are much more likely than women to die of
cancer, a new report from the U.S. National Cancer Institute found.
By Steven Reinberg. In USA Today
http://yourlife.usatoday.com/health/medical/cancer/story/2011/07/Study-More-US-men-die-from-cancer-than-women/49347822/1?csp=34news

Family History of Cancer Needs to Be Updated as You Age
Study shows it can lead to needed changes in screening. By Denise
Mann. In U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/12/family-history-of-cancer-needs-to-be-updated-as-you-age

US girls sweep Google kids science fair
Three US girls won the top prizes in a global science fair launched by
Google for their projects on ovarian cancer, grilled chicken and
indoor air quality, the Internet giant announced Tuesday.
AFP
http://www.google.com/hostednews/afp/article/ALeqM5hXBy_tE0n-oaHT0X40ESLUQHPGmg?docId=CNG.1a520310fd53287b78bc3c012e7eae10.781

After styrene warning, concern about who's at risk
Duffy Mitchell has cut fiberglass, slathered epoxy resin and twisted
rubber hoses at his boat repair shop here on the Chesapeake Bay for
more than a dozen years.
By Ernest Scheyder. Reuters
http://www.reuters.com/article/2011/07/13/us-styrene-idUSTRE76C31K20110713

Scientists Spot Possible Target in Ovarian Cancer
Researchers seeking a way to beat cancer have found that a particular
gene, known as PAX8, is altered in a significant number of ovarian
tumors, according to a new study. The research is part of Project
Achilles, a comprehensive effort by scientists from the Broad
Institute of MIT and Harvard, and the Dana-Farber Cancer Institute to
identify weaknesses in cancers. In U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/12/scientists-spot-possible-target-in-ovarian-cancer

ICGC Releases New Genomic Data on Cancer Ahead of Schedule
The International Cancer Genome Consortium (ICGC) today announced its
sixth major data release at a meeting in Kyoto, Japan. The ICGC also
announced that it is ahead of schedule in its decade-long goal to
generate high-quality genomic data on more than 25,000 tumors for up
to 50 types of cancer that are of clinical and societal importance
across the globe.
PR Newswire (press release)
http://www.prnewswire.com/news-releases/icgc-releases-new-genomic-data-on-cancer-ahead-of-schedule-125349918.html

Bladder Cancer Patients Not Getting Recommended Care: Study
Most patients with a certain type of bladder cancer don't get the
recommended treatments, which greatly increases their risk of
experiencing a recurrence of their disease, researchers say. By Denise
Mann. In U.S. News & World Report
http://health.usnews.com/health-news/managing-your-healthcare/cancer/articles/2011/07/12/bladder-cancer-patients-not-getting-recommended-care-study

Study explains why men are at higher risk for stomach cancer
MIT researchers show how estrogen protects women from the gastric
inflammation that can lead to cancer.
By Anne Trafton. MIT News
http://web.mit.edu/newsoffice/2011/gastric-cancer-0713.html

Nigeria: The Cervical Cancer Challenge
RECENT reports of the serious challenge posed by cervical cancer,
especially in the developing world, which many people are so ignorant
of, are alarming, and the scourge must be tackled head on.
AllAfrica.com
http://allafrica.com/stories/201107120953.html

Hormone therapy shown to prolong life for some prostate cancer
patients
Men diagnosed with prostate cancer are routinely given a harsh hormone
therapy treatment for four months -- it suppresses the production of
the male sex hormone testosterone -- but little was known about how
effective that treatment was at increasing the odds of survival in
those with early- and intermediate-stage disease. So researchers
decided to test whether giving the drugs along with radiation
treatments could prolong a patient’s life.
By Deborah Kotz. In Boston Globe
http://www.boston.com/Boston/dailydose/2011/07/hormone-therapy-shown-prolong-life-for-some-prostate-cancer-patients/CKy5xqnSnf3xsAOGzKOH1O/index.html

Roche's pertuzumab helps breast cancer patients‎
Patients with advanced breast cancer lived significantly longer
without their disease getting worse when treated with Roche's
pertuzumab and Herceptin along with a type of chemotherapy, a late-
stage study showed.
By Katie Reid, Will Waterman. Reuters
http://www.reuters.com/article/2011/07/15/roche-idUSLDE76E01S20110715

Study suggests new way to attack resistant tumours‎
UK scientists have shown that a particular group of chemotherapy drugs
work by causing an unusual form of cell death in cancer cells, called
necroptosis.
Cancer Research UK
http://info.cancerresearchuk.org/news/archive/cancernews/2011-07-14-Study-suggests-new-way-to-attack-resistant-tumours-

Vaccin contre le cancer du col de l’utérus : le Gardasil remis en
cause
Alors que le Gardasil, un des deux vaccins contre le cancer du col de
l’utérus, disponible en France depuis novembre 2006, est décrié par un
collectif de médecins réunionnais, les premières demandes
d’indemnisation voient le jour.
Par Florence Bozec. Dans Futura-Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/vaccin-contre-le-cancer-du-col-de-luterus-le-gardasil-remis-en-cause_31375/

Cancer : 365.000 nouveaux cas en 2011 d'après l'INVS
En 2011, 365.000 personnes s'entendront dire qu'elles ont une tumeur.
C'est ce que prévoit l'Institut de veille sanitaire. Le chiffre
représente une légère hausse, de 2,2 %, par rapport à 2010.
Dans Futura-Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-365000-nouveaux-cas-en-2011-dapres-linvs_31355/

Perturbateurs endocriniens: protéger les mères et les enfants d'abord
Etiqueter des produits contenant des perturbateurs endocriniens pour
protéger les plus vulnérables, les bébés et les femmes enceintes: un
rapport parlementaire, publié mercredi, propose d'agir, sans attendre,
au nom du principe de précaution.
De Brigitte Castelnau. AFP
http://www.google.com/hostednews/afp/article/ALeqM5h2y3dtMJ2JiQlG1AS-i-qG2rvyzw?docId=CNG.2ea01b29a14a71a024e3f1e79f1e3e05.6e1


Roche prévoit demande d'homologation pour le pertuzumab (cancer du
sein HER2)
Roche a atteint ses objectifs d'étude de phase III (CLEOPATRA) avec le
médicament pertuzumab lors de traitement du cancer du sein HER2. Les
résultats de l'étude doivent être présentés cette année encore aux
autorités de la santé au niveau mondial, a indiqué Roche vendredi dans
un communiqué. Le pertuzumab doit être utilisé en combinaison avec
l’herceptin et le docetaxel.
Dans Romandie.com
http://www.romandie.com/news/n/Roche_prevoit_demande_d_homologation_pour_Pertuzumab_cancer_du_sein_HER2_dev150720111007.asp

"Pour les nuls" propose un nouveau guide pour mieux comprendre le
cancer
La série des Nuls s'agrandit avec un nouveau guide pratique,
entièrement dédié à tous les types de cancers. Proposé par les
Editions First, cet ouvrage répond à toutes les questions que peuvent
se poser les patients et leur entourage sur le cancer, et tente de
lutter contre les idées reçues.
Dans Le Parisien
http://www.leparisien.fr/laparisienne/sante/pour-les-nuls-propose-un-nouveau-guide-pour-mieux-comprendre-le-cancer-13-07-2011-1532703.php

Santé et internet: un nouveau "savoir profane" émerge des réseaux
sociaux
L'essor d'internet et des réseaux sociaux de santé fait émerger un
nouveau savoir collectif, ou "profane", au côté du savoir médical,
transformant la relation malade-médecin mais aussi la façon dont est
vécue la maladie, selon une enquête réalisée par des sociologues.
Par Véronique Martinache. AFP
http://www.google.com/hostednews/afp/article/ALeqM5iGAnf-O3Gj1-nv7z-uMWgEgBvQpw?docId=CNG.f924baf2a7e4381be48d55dfd841115b.371

Augmentation alarmante des cas du cancer du sein : 1006 nouveaux cas
cette année et trois ablations chaque semaine
Le taux d’incidence, c’est-à-dire le nombre de nouveaux cas, de cette
maladie Ă  Oran, est de 20 cas pour 100.000 femmes.
Dans El Watan
http://www.elwatan.com/regions/ouest/oran/1-006-nouveaux-cas-cette-annee-et-trois-ablations-chaque-semaine-14-07-2011-132607_135.php





Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix – Oncowal & Wallogene (07/2011)
Technical Details
Message-ID: <dfaf9f73-0b66-4234-aee2-78650d6753f2@q1g2000vbj.googlegroups.com>
Path: arc1-ca.pugleaf.net!g2news1.google.com!postnews.google.com!q1g2000vbj.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: a254ea4a8d,58fa3c2483e2b956,start
X-Google-Attributes: gida254ea4a8d,public,usenet
X-Google-NewGroupId: yes
X-Google-Language: ENGLISH,UTF8
Path: arc1-ca.pugleaf.net!g2news1.google.com!postnews.google.com!q1g2000vbj.googlegroups.com!not-for-mail
From: SciMedWeb <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press review  (July 16, 2011) – Revue de presse (16 juillet 2011)
Date: Sat, 16 Jul 2011 01:38:58 -0700 (PDT)
Organization: http://groups.google.com
Lines: 213
Message-ID: <dfaf9f73-0b66-4234-aee2-78650d6753f2@q1g2000vbj.googlegroups.com>
NNTP-Posting-Host: 81.247.49.77
Mime-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable
X-Trace: posting.google.com 1310806474 13622 127.0.0.1 (16 Jul 2011 08:54:34 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 16 Jul 2011 08:54:34 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: q1g2000vbj.googlegroups.com; posting-host=81.247.49.77; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-Google-Web-Client: true
X-Google-Header-Order: UHALERCNK
X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.8.131 Version/11.11,gzip(gfe)